Badi Soch: Ranbaxy verdict a setback for India’s IPR battle

This daily column includes Gateway House’s Badi Soch – big thought – of the day’s foreign policy events. Today’s focus is on the $500 million fine levied on Ranbaxy by the U.S. Food and Drug Administration.